About this Journal Submit a Manuscript Table of Contents
ISRN Immunology
Volume 2012 (2012), Article ID 853123, 17 pages
http://dx.doi.org/10.5402/2012/853123
Review Article

Host Defence against Bacterial Biofilms: “Mission Impossible”?

Institute for Immunology, University of Heidelberg, 69120 Heidelberg, Germany

Received 11 September 2012; Accepted 4 October 2012

Academic Editors: C. Faveeuw, D. Lilic, P. Puccetti, and A. Taylor-Robinson

Copyright © 2012 Gertrud Maria Hänsch. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Costerton, “Introduction to biofilm,” International Journal of Antimicrobial Agents, vol. 11, no. 3-4, pp. 217–221, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Costerton, R. Veeh, M. Shirtliff, M. Pasmore, C. Post, and G. Ehrlich, “The application of biofilm science to the study and control of chronic bacterial infections,” Journal of Clinical Investigation, vol. 112, no. 10, pp. 1466–1477, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. R. Parsek and P. K. Singh, “Bacterial biofilms: an emerging link to disease pathogenesis,” Annual Review of Microbiology, vol. 57, pp. 677–701, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Hall-Stoodley and P. Stoodley, “Biofilm formation and dispersal and the transmission of human pathogens,” Trends in Microbiology, vol. 13, no. 1, pp. 7–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Prince, “Biofilms, antimicrobial resistance, and airway infection,” New England Journal of Medicine, vol. 347, no. 14, pp. 1110–1111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. W. J. Looney, M. Narita, and K. Mühlemann, “Stenotrophomonas maltophilia: an emerging opportunist human pathogen,” The Lancet Infectious Diseases, vol. 9, no. 5, pp. 312–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Hall-Stoodley and P. Stoodley, “Evolving concepts in biofilm infections,” Cellular Microbiology, vol. 11, no. 7, pp. 1034–1043, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. C. Flemming, “Biofouling in water systems—cases, causes and countermeasures,” Applied Microbiology and Biotechnology, vol. 59, no. 6, pp. 629–640, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. W. M. Dunne Jr., “Bacterial adhesion: seen any good biofilms lately?” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 155–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. R. M. Donlan and J. W. Costerton, “Biofilms: survival mechanisms of clinically relevant microorganisms,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 167–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. R. Johnson, “Microcolony and biofilm formation as a survival strategy for bacteria,” Journal of Theoretical Biology, vol. 251, no. 1, pp. 24–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Macfarlane and J. F. Dillon, “Microbial biofilms in the human gastrointestinal tract,” Journal of Applied Microbiology, vol. 102, no. 5, pp. 1187–1196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Sproule-Willoughby, M. M. Stanton, K. P. Rioux, D. M. McKay, A. G. Buret, and H. Ceri, “In vitro anaerobic biofilms of human colonic microbiota,” Journal of Microbiological Methods, vol. 83, no. 3, pp. 296–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. O'Toole, H. B. Kaplan, and R. Kolter, “Biofilm formation as microbial development,” Annual Review of Microbiology, vol. 54, pp. 49–79, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Hall-Stoodley, J. W. Costerton, and P. Stoodley, “Bacterial biofilms: from the natural environment to infectious diseases,” Nature Reviews Microbiology, vol. 2, no. 2, pp. 95–108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Stoodley, K. Sauer, D. G. Davies, and J. W. Costerton, “Biofilms as complex differentiated communities,” Annual Review of Microbiology, vol. 56, pp. 187–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Karatan and P. Watnick, “Signals, regulatory networks, and materials that build and break bacterial biofilms,” Microbiology and Molecular Biology Reviews, vol. 73, no. 2, pp. 310–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Fuqua and E. P. Greenberg, “Listening in on bacteria: acyl-homoserine lactone signalling,” Nature Reviews Molecular Cell Biology, vol. 3, no. 9, pp. 685–695, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. K. K. Jefferson, “What drives bacteria to produce a biofilm?” FEMS Microbiology Letters, vol. 236, no. 2, pp. 163–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Molin and T. Tolker-Nielsen, “Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure,” Current Opinion in Biotechnology, vol. 14, no. 3, pp. 255–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Wuertz, S. Okabe, and M. Hausner, “Microbial communities and their interactions in biofilm systems: an overview,” Water Science and Technology, vol. 49, no. 11-12, pp. 327–336, 2004. View at Scopus
  22. R. M. Donlan, “Role of biofilms antimicrobial resistance,” ASAIO Journal, vol. 46, no. 6, pp. S47–S52, 2000. View at Scopus
  23. P. S. Stewart and J. W. Costerton, “Antibiotic resistance of bacteria in biofilms,” Lancet, vol. 358, no. 9276, pp. 135–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Whiteley, M. G. Bangera, R. E. Bumgarner et al., “Gene expression in Pseudomonas aeruginosa biofilms,” Nature, vol. 413, no. 6858, pp. 860–864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. T. F. C. Mah and G. A. O'Toole, “Mechanisms of biofilm resistance to antimicrobial agents,” Trends in Microbiology, vol. 9, no. 1, pp. 34–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Neut, J. R. Van Horn, T. G. Van Kooten, H. C. Van Der Mei, and H. J. Busscher, “Detection of biomaterial-associated infections in orthopaedic joint implants,” Clinical Orthopaedics and Related Research, no. 413, pp. 261–268, 2003. View at Scopus
  27. A. Trampuz, D. R. Osmon, A. D. Hanssen, J. M. Steckelberg, and R. Patel, “Molecular and antibiofilm approaches to prosthetic joint infection,” Clinical Orthopaedics and Related Research, no. 414, pp. 69–88, 2003. View at Scopus
  28. C. L. Nelson, A. C. McLaren, S. G. McLaren, J. W. Johnson, and M. S. Smeltzer, “Is aseptic loosening truly aseptic?” Clinical Orthopaedics and Related Research, no. 437, pp. 25–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. B. Lyczak, C. L. Cannon, and G. B. Pier, “Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist,” Microbes and Infection, vol. 2, no. 9, pp. 1051–1060, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. K. G. Kerr and A. M. Snelling, “Pseudomonas aeruginosa: a formidable and ever-present adversary,” Journal of Hospital Infection, vol. 73, no. 4, pp. 338–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Hoiby, E. W. Flensborg, B. Beck, et al., “Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis,” Scandinavian Journal of Respiratory Diseases, vol. 58, pp. 65–79, 1977.
  32. J. R. W. Govan and V. Deretic, “Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia,” Microbiological Reviews, vol. 60, no. 3, pp. 539–574, 1996. View at Scopus
  33. D. G. Downey, S. C. Bell, and J. S. Elborn, “Neutrophils in cystic fibrosis,” Thorax, vol. 64, no. 1, pp. 81–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. W. Costerton, “Cystic fibrosis pathogenesis and the role of biofilms in persistent infection,” Trends in Microbiology, vol. 9, no. 2, pp. 50–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. G. B. Pier, “Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 8822–8828, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Bjarnsholt, K. Kirketerp-Møller, P. Ø. Jensen et al., “Why chronic wounds will not heal: a novel hypothesis,” Wound Repair and Regeneration, vol. 16, no. 1, pp. 2–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. A. James, E. Swogger, R. Wolcott et al., “Biofilms in chronic wounds,” Wound Repair and Regeneration, vol. 16, no. 1, pp. 37–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Hall-Stoodley, F. Z. Hu, A. Gieseke et al., “Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media,” Journal of the American Medical Association, vol. 296, no. 2, pp. 202–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Chen, “Periodontitis as a biofilm infection,” Journal of the California Dental Association, vol. 29, no. 5, pp. 362–369, 2001. View at Scopus
  40. C. Schaudinn, A. Gorur, D. Keller, P. P. Sedghizadeh, and J. W. Costerton, “Periodontitis: an archetypical biofilm disease,” Journal of the American Dental Association, vol. 140, no. 8, pp. 978–986, 2009. View at Scopus
  41. J. Cryer, I. Schipor, J. R. Perloff, and J. N. Palmer, “Evidence of bacterial biofilms in human chronic sinusitis,” Journal for Oto-Rhino-Laryngology, vol. 66, no. 3, pp. 155–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. C. N. Burkhart and C. G. Burkhart, “Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris,” International Journal of Dermatology, vol. 42, no. 12, pp. 925–927, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Coenye, K. Honraet, B. Rossel, and H. J. Nelis, “Biofilms in skin infections: propionibacterium acnes and acne vulgaris,” Infectious Disorders, vol. 8, no. 3, pp. 156–159, 2008. View at Scopus
  44. S. E. Dowd, R. D. Wolcott, Y. Sun, T. McKeehan, E. Smith, and D. Rhoads, “Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP),” PLoS ONE, vol. 3, no. 10, Article ID e3326, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. A. S. Lynch and G. T. Robertson, “Bacterial and fungal biofilm infections,” Annual Review of Medicine, vol. 59, pp. 415–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Tolker-Nielsen, U. C. Brinch, P. C. Ragas, J. B. Andersen, C. S. Jacobsen, and S. Molin, “Development and dynamics of Pseudomonas sp. biofilms,” Journal of Bacteriology, vol. 182, no. 22, pp. 6482–6489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Harmsen, L. Yang, S. J. Pamp, and T. Tolker-Nielsen, “An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal,” FEMS Immunology and Medical Microbiology, vol. 59, no. 3, pp. 253–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Wagner, S. Aytac, and G. M. Hansch, “Biofilm growth on implants: bacteria prefer plasma coats,” International Journal of Artificial Organs, vol. 34, pp. 811–817, 2011.
  49. A. G. Gristina, P. Naylor, and Q. Myrvik, “Infections from biomaterials and implants: a race for the surface,” Medical Progress through Technology, vol. 14, no. 3-4, pp. 205–224, 1988. View at Scopus
  50. C. K. Chun, E. A. Ozer, M. J. Welsh, J. Zabner, and E. P. Greenberg, “Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3587–3590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. J. W. Hastings, “Bacterial quorum-sensing signals are inactivated by mammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 3993–3994, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Høiby, “Inflammation and infection in cystic fibrosis—hen or egg?” European Respiratory Journal, vol. 17, no. 1, pp. 4–5, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. P. B. Davis, “Cystic fibrosis since 1938,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 5, pp. 475–482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. G. B. Pier, “The challenges and promises of new therapies for cystic fibrosis,” The Journal of Experimental Medicine, vol. 209, pp. 1235–1239, 2012.
  55. S. S. Pedersen, N. Hoiby, F. Espersen, and C. Koch, “Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis,” Thorax, vol. 47, no. 1, pp. 6–13, 1992. View at Scopus
  56. D. P. Lew and F. A. Waldvogel, “Current concepts: osteomyelitis,” New England Journal of Medicine, vol. 336, no. 14, pp. 999–1007, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Zimmerli, A. Trampuz, and P. E. Ochsner, “Current concepts: prosthetic-joint infections,” New England Journal of Medicine, vol. 351, no. 16, pp. 1645–1654, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. J. W. Costerton, L. Montanaro, and C. R. Arciola, “Biofilm in implant infections: its production and regulation,” International Journal of Artificial Organs, vol. 28, no. 11, pp. 1062–1068, 2005. View at Scopus
  59. C. A. Fux, J. W. Costerton, P. S. Stewart, and P. Stoodley, “Survival strategies of infectious biofilms,” Trends in Microbiology, vol. 13, no. 1, pp. 34–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. L. G. Harris and R. G. Richards, “Staphylococci and implant surfaces: a review,” Injury, vol. 37, no. 2, pp. S3–S14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. L. A. Poultsides, L. L. Liaropoulus, and K. N. Malizos, “The socioeconomic Impact of Musculoskeletal Infections,” The Journal of Bone & Joint Surgery, vol. 92, no. 11, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. C. R. Arciola, “Why focus on implant infections?” International Journal of Artificial Organs, vol. 28, no. 11, pp. 1060–1061, 2005. View at Scopus
  63. C. Wagner, K. Kondella, T. Bernschneider, V. Heppert, A. Wentzensen, and G. M. Hänsch, “Post-traumatic osteomyelitis: analysis of inflammatory cells recruited into the site of infection,” Shock, vol. 20, no. 6, pp. 503–510, 2003. View at Scopus
  64. M. M. Gaida, F. Günther, C. Wagner et al., “Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections,” Clinical and Experimental Immunology, vol. 154, no. 2, pp. 216–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Wagner, A. Kaksa, W. Müller et al., “Polymorphonuclear neutrophils in posttraumatic osteomyelitis: cells recovered from the inflamed site lack chemotactic activity but generate superoxides,” Shock, vol. 22, no. 2, pp. 108–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Wagner, D. Heck, K. Lautenschläger et al., “T lymphocytes in implant-associated posttraumatic osteomyelitis: identification of cytotoxic T effector cells at the site of infection,” Shock, vol. 25, no. 3, pp. 241–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Kotsougiani, M. Pioch, B. Prior, V. Heppert, G. M. Hansch, and C. Wagner, “Activation of T lymphocytes in response to persistent bacterial infection: induction of CD11b and of toll-like receptors on T cells,” International Journal of Inflammation, vol. 2010, Article ID 526740, 10 pages, 2010. View at Publisher · View at Google Scholar
  68. M. M. Gaida, B. Mayer, S. Stegmaier, P. Schirmacher, C. Wagner, and G.M. Hänsch, “Polymorphonuclear neutrophils in osteomyelitis: link to osteoclast generation and bone resorption,” European Journal of Inflammation. In press.
  69. H. Tlaskalova-Hogenova, R. Stepankova, T. Hudcovic, et al., “Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases,” Immunology Letters, vol. 93, pp. 97–108, 2004.
  70. A. J. Macpherson and N. L. Harris, “Interactions between commensal intestinal bacteria and the immune system,” Nature Reviews Immunology, vol. 4, no. 6, pp. 478–485, 2004. View at Scopus
  71. D. Kelly, S. Conway, and R. Aminov, “Commensal gut bacteria: mechanisms of immune modulation,” Trends in Immunology, vol. 26, no. 6, pp. 326–333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. S. L. Russell, M. J. Gold, and M. Hartmann, “Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma,” EMBO Reports, vol. 13, pp. 440–447, 2012.
  73. D. M. Underhill and A. Ozinsky, “Phagocytosis of microbes: complexity in action,” Annual Review of Immunology, vol. 20, pp. 825–852, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. L. M. Stuart and R. A. B. Ezekowitz, “Phagocytosis: elegant complexity,” Immunity, vol. 22, no. 5, pp. 539–550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Fournier and D. J. Philpott, “Recognition of Staphylococcus aureus by the innate immune system,” Clinical Microbiology Reviews, vol. 18, no. 3, pp. 521–540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. M. C. Dinauer, “Disorders of neutrophil function: an overview,” Methods in Molecular Biology, vol. 412, pp. 489–504, 2007. View at Scopus
  77. N. Berliner, M. Horwitz, and T. P. Loughran, “Congenital and acquired neutropenia,” Hematology, pp. 63–79, 2004. View at Scopus
  78. L. Notarangelo, J. L. Casanova, A. Fischer et al., “Primary immunodeficiency diseases: an update,” Journal of Allergy and Clinical Immunology, vol. 114, no. 3, pp. 677–687, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Friedl and B. Weigelin, “Interstitial leukocyte migration and immune function,” Nature Immunology, vol. 9, no. 9, pp. 960–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. C. H. Y. Wong, B. Heit, and P. Kubes, “Molecular regulators of leucocyte chemotaxis during inflammation,” Cardiovascular Research, vol. 86, no. 2, pp. 183–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. V. Witko-Sarsat, P. Rieu, B. Descamps-Latscha, P. Lesavre, and L. Halbwachs-Mecarelli, “Neutrophils: molecules, functions and pathophysiological aspects,” Laboratory Investigation, vol. 80, no. 5, pp. 617–654, 2000. View at Scopus
  82. D. Rossi and A. Zlotnik, “The biology of chemokines and their receptors,” Annual Review of Immunology, vol. 18, pp. 217–243, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Gerard and N. P. Gerard, “Chemokines: back to the future?” Nature Cell Biology, vol. 3, no. 2, pp. E53–E54, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Kobayashi, “The role of chemokines in neutrophil biology,” Frontiers in Bioscience, vol. 13, no. 7, pp. 2400–2407, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. E. Schiffmann, H. V. Showell, and B. A. Corcoran, “The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli,” Journal of Immunology, vol. 114, no. 6, pp. 1831–1837, 1975. View at Scopus
  86. Y. Miyake, T. Yasuhara, and K. Fukui, “Purification and characterization of neutrophil chemotactic factors of Streptococcus sanguis,” Biochimica et Biophysica Acta, vol. 758, no. 2, pp. 181–186, 1983. View at Publisher · View at Google Scholar · View at Scopus
  87. W. A. Marasco, S. H. Phan, and H. Krutzsch, “Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli,” Journal of Biological Chemistry, vol. 259, no. 9, pp. 5430–5439, 1984. View at Scopus
  88. S. Zimmermann, C. Wagner, W. Müller et al., “Induction of neutrophil chemotaxis by the quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone,” Infection and Immunity, vol. 74, no. 10, pp. 5687–5692, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. N. A. Kahle, G. Brenner-Weiss, J. Overhage, U. Obst, and G. M. Hansch, “Bacterial quorum sensing molecule induces chemotaxis of human neutrophils via induction of p38 and leukocyte specific protein 1 (LSP1),” Immunobiology. In press. View at Publisher · View at Google Scholar
  90. E. Vikström, K. E. Magnusson, and A. Pivoriunas, “The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L- homoserine lactone stimulates phagocytic activity in human macrophages through the p38 MAPK pathway,” Microbes and Infection, vol. 7, no. 15, pp. 1512–1518, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Karlsson, F. Musse, K. E. Magnusson, and E. Vikstrom, “N-Acylhomoserine lactones are potent neutrophil chemoattractants that act via calcium mobilization and actin remodeling,” Journal of Leukocyte Biology, vol. 91, pp. 15–26, 2012.
  92. H. M. Chapel, R. Geha, and F. Rosen, “Primary immunodeficiency diseases: an update,” Clinical and Experimental Immunology, vol. 132, no. 1, pp. 9–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. J. A. Lekstrom-Himes and J. I. Gallin, “Immunodeficiency diseases caused by defects in phagocytes,” New England Journal of Medicine, vol. 343, no. 23, pp. 1703–1714, 2000. View at Publisher · View at Google Scholar · View at Scopus
  94. N. Borregaard, “Neutrophils, from Marrow to microbes,” Immunity, vol. 33, no. 5, pp. 657–670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Häger, J. B. Cowland, and N. Borregaard, “Neutrophil granules in health and disease,” Journal of Internal Medicine, vol. 268, no. 1, pp. 25–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. E. Meyle, P. Stroh, F. Günther, T. Hoppy-Tichy, C. Wagner, and G. M. Hänsch, “Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release, and degranulation,” International Journal of Artificial Organs, vol. 33, no. 9, pp. 608–620, 2010. View at Scopus
  97. P. K. Singh, M. R. Parsek, E. P. Greenberg, and M. J. Welsh, “A component of innate immunity prevents bacterial biofilm development,” Nature, vol. 417, no. 6888, pp. 552–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Ganz, “Defensins: antimicrobial peptides of innate immunity,” Nature Reviews Immunology, vol. 3, no. 9, pp. 710–720, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. K. L. Brown and R. E. W. Hancock, “Cationic host defense (antimicrobial) peptides,” Current Opinion in Immunology, vol. 18, no. 1, pp. 24–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Peschel, “How do bacteria resist human antimicrobial peptides?” Trends in Microbiology, vol. 10, no. 4, pp. 179–186, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Ozinsky, D. M. Underhill, J. D. Fontenot et al., “The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13766–13771, 2000. View at Publisher · View at Google Scholar · View at Scopus
  102. R. Medzhitov and C. A. Janeway Jr., “Decoding the patterns of self and nonself by the innate immune system,” Science, vol. 296, no. 5566, pp. 298–300, 2002. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Akira and H. Hemmi, “Recognition of pathogen-associated molecular patterns by TLR family,” Immunology Letters, vol. 85, no. 2, pp. 85–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  104. J. A. Hoffmann, F. C. Kafatos, C. A. Janeway, and R. A. B. Ezekowitz, “Phylogenetic perspectives in innate immunity,” Science, vol. 284, no. 5418, pp. 1313–1318, 1999. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Nürnberger and F. Brunner, “Innate immunity in plants and animals: emerging parallels between the recognition of general elicitors and pathogen-associated molecular patterns,” Current Opinion in Plant Biology, vol. 5, no. 4, pp. 318–324, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. S. D. Wright, R. A. Ramos, A. Hermanowski-Vosatka, P. Rockwell, and P. A. Detmers, “Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14,” Journal of Experimental Medicine, vol. 173, no. 5, pp. 1281–1286, 1991. View at Scopus
  107. M. Triantafilou and K. Triantafilou, “Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster,” Trends in Immunology, vol. 23, no. 6, pp. 301–304, 2002. View at Publisher · View at Google Scholar · View at Scopus
  108. P. J. Gough and S. Gordon, “The role of scavenger receptors in the innate immune system,” Microbes and Infection, vol. 2, no. 3, pp. 305–311, 2000. View at Publisher · View at Google Scholar · View at Scopus
  109. T. Areschoug and S. Gordon, “Scavenger receptors: role in innate immunity and microbial pathogenesis,” Cellular Microbiology, vol. 11, no. 8, pp. 1160–1169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. C. B. Whitchurch, T. Tolker-Nielsen, P. C. Ragas, and J. S. Mattick, “Extracellular DNA required for bacterial biofilm formation,” Science, vol. 295, no. 5559, p. 1487, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. K. C. Rice, E. E. Mann, J. L. Endres et al., “The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 19, pp. 8113–8118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. A. L. Spoering and M. S. Gilmore, “Quorum sensing and DNA release in bacterial biofilms,” Current Opinion in Microbiology, vol. 9, no. 2, pp. 133–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. H. Wagner, “The immunobiology of the TLR9 subfamily,” Trends in Immunology, vol. 25, no. 7, pp. 381–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  114. A. S. Trevani, A. Chorny, G. Salamone et al., “Bacterial DNA activates human neutrophils by a CpG-independent pathway,” European Journal of Immunology, vol. 33, no. 11, pp. 3164–3174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. M. E. Alvarez, J. I. F. Bass, J. R. Geffner et al., “Neutrophil signaling pathways activated by bacterial DNA stimulation,” Journal of Immunology, vol. 177, no. 6, pp. 4037–4046, 2006. View at Scopus
  116. D. El Kebir, L. József, and J. G. Filep, “Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function,” Archivum Immunologiae et Therapiae Experimentalis, vol. 56, no. 1, pp. 41–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. K. J. Ishii, S. Koyama, A. Nakagawa, C. Coban, and S. Akira, “Host innate immune receptors and beyond: making sense of microbial infections,” Cell Host and Microbe, vol. 3, no. 6, pp. 352–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. J. Verhoef, P. K. Peterson, and Y. Kim, “Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains,” Immunology, vol. 33, no. 2, pp. 191–197, 1977. View at Scopus
  119. M. M. Frank and L. F. Fries, “The role of complement in inflammation and phagocytosis,” Immunology Today, vol. 12, no. 9, pp. 322–326, 1991. View at Scopus
  120. K. M. Cunnion and M. M. Frank, “Complement activation influences Staphylococcus aureus adherence to endothelial cells,” Infection and Immunity, vol. 71, no. 3, pp. 1321–1327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  121. E. J. Brown, “Complement receptors and phagocytosis,” Current Opinion in Immunology, vol. 3, pp. 76–82, 1991.
  122. J. V. Ravetch and R. A. Clynes, “Divergent roles for Fc receptors and complement in vivo,” Annual Review of Immunology, vol. 16, pp. 421–432, 1998. View at Publisher · View at Google Scholar · View at Scopus
  123. J. V. Ravetch and S. Bolland, “IgG Fc receptors,” Annual Review of Immunology, vol. 19, pp. 275–290, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. S. Rivas-Fuentes, E. García-García, G. Nieto-Castañeda, and C. Rosales, “Fcγ receptors exhibit different phagocytosis potential in human neutrophils,” Cellular Immunology, vol. 263, no. 1, pp. 114–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. D. M. Underhill and H. S. Goodridge, “Information processing during phagocytosis,” Nature Reviews Immunology, vol. 12, pp. 492–502, 2012.
  126. D. C. Hodgins and P. E. Shewen, “Subversion of the immune response by bacterial pathogens,” in Pathogenesis of Bacterial Infections in Animals, pp. 15–32, Wiley-Blackwell, 2010.
  127. F. R. DeLeo, B. A. Diep, and M. Otto, “Host defense and pathogenesis in Staphylococcus aureus infections,” Infectious Disease Clinics of North America, vol. 23, no. 1, pp. 17–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. T. J. Foster, “Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion,” Veterinary Dermatology, vol. 20, no. 5-6, pp. 456–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. D. M. Veltman, I. Keizer-Gunnik, and P. J. M. Van Haastert, “Four key signaling pathways mediating chemotaxis in Dictyostelium discoideum,” Journal of Cell Biology, vol. 180, no. 4, pp. 747–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. A. Bagorda and C. A. Parent, “Eukaryotic chemotaxis at a glance,” Journal of Cell Science, vol. 121, no. 16, pp. 2621–2624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. J. S. King and R. H. Insall, “Chemotaxis: finding the way forward with Dictyostelium,” Trends in Cell Biology, vol. 19, no. 10, pp. 523–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  132. S. S. Branda, S. Vik, L. Friedman, and R. Kolter, “Biofilms: the matrix revisited,” Trends in Microbiology, vol. 13, no. 1, pp. 20–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. I. W. Sutherland, “The biofilm matrix—an immobilized but dynamic microbial environment,” Trends in Microbiology, vol. 9, no. 5, pp. 222–227, 2001. View at Publisher · View at Google Scholar · View at Scopus
  134. H. C. Flemming and J. Wingender, “The biofilm matrix,” Nature Reviews Microbiology, vol. 8, no. 9, pp. 623–633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  135. A. J. Jesaitis, M. J. Franklin, D. Berglund et al., “Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions,” Journal of Immunology, vol. 171, no. 8, pp. 4329–4339, 2003. View at Scopus
  136. E. Tvenstrup Jensen, A. Kharazmi, N. Hoiby, and J. W. Costeron, “Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms,” Acta Pathologica, Microbiologica et Immunologica, vol. 100, no. 8, pp. 727–733, 1992. View at Scopus
  137. A. Kharazmi, “Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa,” Immunology Letters, vol. 30, no. 2, pp. 201–206, 1991. View at Publisher · View at Google Scholar · View at Scopus
  138. A. Kharazmi and H. Nielsen, “Inhibition of human monocyte chemotaxis and chemiluminescence by Pseudomonas aeruginosa elastase,” Acta Pathologica, Microbiologica et Immunologica, vol. 99, no. 1, pp. 93–95, 1991. View at Scopus
  139. J. G. Leid, C. J. Willson, M. E. Shirtliff, D. J. Hassett, M. R. Parsek, and A. K. Jeffers, “The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-γ-mediated macrophage killing,” Journal of Immunology, vol. 175, no. 11, pp. 7512–7518, 2005. View at Scopus
  140. G. M. Hänsch, G. Brenner-Weiss, B. Prior, C. Wagner, and U. Obst, “The extracellular matrix of Pseudomonas aeruginosa: too slippery to migrate on?” International Journal of Artificial Organs, vol. 31, pp. 796–803, 2008.
  141. D. W. Martin, M. J. Schurr, M. H. Mudd, J. R. W. Govan, B. W. Holloway, and V. Deretic, “Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 18, pp. 8377–8381, 1993. View at Scopus
  142. M. Hentzer, G. M. Teitzel, G. J. Balzer et al., “Alginate overproduction affects pseudomonas aeruginosa biofilm structure and function,” Journal of Bacteriology, vol. 183, no. 18, pp. 5395–5401, 2001. View at Publisher · View at Google Scholar · View at Scopus
  143. F. G. Jarvis and M. J. Johnson, “A glyco-lipide produced by Pseudomonas Aeruginosa,” The Journal of the American Chemical Society, vol. 71, no. 12, pp. 4124–4126, 1949. View at Scopus
  144. U. A. Ochsner, J. Reiser, A. Fiechter, and B. Witholt, “Production of Pseudomonas aeruginosa rhamnolipid biosurfactants in heterologous hosts,” Applied and Environmental Microbiology, vol. 61, no. 9, pp. 3503–3506, 1995. View at Scopus
  145. J. P. Pearson, E. C. Pesci, and B. H. Iglewski, “Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes,” Journal of Bacteriology, vol. 179, no. 18, pp. 5756–5767, 1997. View at Scopus
  146. M. E. Davey, N. C. Caiazza, and G. A. O'Toole, “Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1,” Journal of Bacteriology, vol. 185, no. 3, pp. 1027–1036, 2003. View at Publisher · View at Google Scholar · View at Scopus
  147. A. Kharazmi, Z. Bibi, H. Nielsen, N. Hoiby, and G. Doring, “Effect of Pseudomonas aeruginosa rhamnolipid on human neutrophil and monocyte function,” Acta Pathologica, Microbiologica et Immunologica, vol. 97, no. 12, pp. 1068–1072, 1989. View at Scopus
  148. T. R. Shryock, S. A. Silver, M. W. Banschbach, and J. C. Kramer, “Effect of Pseudomonas aeruginosa rhamnolipid on human neutrophil migration,” Current Microbiology, vol. 10, no. 6, pp. 323–328, 1984. View at Scopus
  149. P. Ø. Jensen, T. Bjarnsholt, R. Phipps et al., “Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa,” Microbiology, vol. 153, no. 5, pp. 1329–1338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. P. O. Jensen, M. Givskov, T. Bjarnsholt, and C. Moser, “The immune system vs. Pseudomonas aeruginosa biofilms,” FEMS Immunology and Medical Microbiology, vol. 59, no. 3, pp. 292–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. M. van Gennip, L. D. Christensen, M. Alhede et al., “Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo,” Infection and Immunity, vol. 80, pp. 2601–2607, 2012.
  152. K. C. Meyer and J. Zimmerman, “Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis,” Journal of Laboratory and Clinical Medicine, vol. 121, no. 5, pp. 654–661, 1993. View at Scopus
  153. J. B. Lyczak, C. L. Cannon, and G. B. Pier, “Lung infections associated with cystic fibrosis,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 194–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
  154. M. Conese, E. Copreni, S. Di Gioia, P. De Rinaldis, and R. Fumarulo, “Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease,” Journal of Cystic Fibrosis, vol. 2, no. 3, pp. 129–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  155. A. P. Watt, J. Courtney, J. Moore, M. Ennis, and J. S. Elborn, “Neutrophil cell death, activation and bacterial infection in cystic fibrosis,” Thorax, vol. 60, no. 8, pp. 659–664, 2005. View at Publisher · View at Google Scholar · View at Scopus
  156. M. W. Konstan, K. A. Hilliard, T. M. Norvell, and M. Berger, “Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 2, pp. 448–454, 1994. View at Scopus
  157. K. C. Meyer, J. R. Lewandoski, J. J. Zimmerman, D. Nunley, W. J. Calhoun, and G. A. Dopico, “Human neutrophil elastase and elastase/alpha1-antiprotease complex in cystic fibrosis: comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy,” American Review of Respiratory Disease, vol. 144, no. 3 I, pp. 580–585, 1991. View at Scopus
  158. M. Alhede, T. Bjarnsholt, P. Ø. Jensen et al., “Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes,” Microbiology, vol. 155, no. 11, pp. 3500–3508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. G. Luo, D. W. Niesel, R. A. Shaban, E. A. Grimm, and G. R. Klimpel, “Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties,” Infection and Immunity, vol. 61, no. 3, pp. 830–835, 1993. View at Scopus
  160. G. Umberto Meduri, S. Kanangat, J. Stefan, E. Tolley, and D. Schaberg, “Cytokines IL-1β, IL-6, and TNF-α enhance in vitro growth of bacteria,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 3, pp. 961–967, 1999. View at Scopus
  161. S. Kanangat, M. S. Bronze, G. Umberto Meduri et al., “Enhanced extracellular growth of Staphylococcus aureus in the presence of selected linear peptide fragments of human interleukin (IL)-1β and IL-1 receptor antagonist,” Journal of Infectious Diseases, vol. 183, no. 1, pp. 65–69, 2001. View at Publisher · View at Google Scholar · View at Scopus
  162. L. Wu, O. Estrada, O. Zaborina et al., “Microbiology: recognition of host immune activation by Pseudomonas aeruginosa,” Science, vol. 309, no. 5735, pp. 774–777, 2005. View at Publisher · View at Google Scholar · View at Scopus
  163. E. Banin, M. L. Vasil, and E. P. Greenberg, “Iron and Pseudomonas aeruginosa biofilm formation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 31, pp. 11076–11081, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. C. Y. O'May, K. Sanderson, L. F. Roddam, S. M. Kirov, and D. W. Reid, “Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions,” Journal of Medical Microbiology, vol. 58, no. 6, pp. 765–773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. A. J. Psaltis, P. J. Wormald, K. R. Ha, and L. W. Tan, “Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis,” Laryngoscope, vol. 118, no. 5, pp. 895–901, 2008. View at Publisher · View at Google Scholar · View at Scopus
  166. B. E. Britigan, M. B. Hayek, B. N. Doebbeling, and R. B. Fick Jr., “Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis,” Infection and Immunity, vol. 61, no. 12, pp. 5049–5055, 1993. View at Scopus
  167. M. P. Rogan, C. C. Taggart, C. M. Greene, P. G. Murphy, S. J. O'Neill, and N. G. McElvaney, “Loss of microbial activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis,” Journal of Infectious Diseases, vol. 190, no. 7, pp. 1245–1253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  168. P. Geraghty, M. P. Rogan, C. M. Greene et al., “Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression,” Journal of Immunology, vol. 178, no. 9, pp. 5871–5878, 2007. View at Scopus
  169. D. R. Ammons, R. Puttagunta, J. C. Granados, G. de la Garza, G. S. Eyambe, and J. Rampersad, “An exploratory study of methicillin-resistant Staphylococcus aureus and SCCmec elements obtained from a community setting along the Texas border with Mexico,” Current Microbiology, vol. 60, no. 5, pp. 321–326, 2010. View at Scopus
  170. M. C. B. Ammons, L. S. Ward, and G. A. James, “Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings,” International Wound Journal, vol. 8, no. 3, pp. 268–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  171. R. D. Wolcott and D. D. Rhoads, “A study of biofilm-based wound management in subjects with critical limb ischaemia,” Journal of Wound Care, vol. 17, no. 4, pp. 145–155, 2008. View at Scopus
  172. S. C. Davis, L. Martinez, and R. Kirsner, “The diabetic foot: the importance of biofilms and wound bed preparation,” Current Diabetes Reports, vol. 6, no. 6, pp. 439–445, 2006. View at Publisher · View at Google Scholar · View at Scopus
  173. K. E. Hill, S. Malic, R. McKee et al., “An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 6, pp. 1195–1206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  174. A. Nijnik and R. E. W. Hancock, “The roles of cathelicidin LL-37 in immune defences and novel clinical applications,” Current Opinion in Hematology, vol. 16, no. 1, pp. 41–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  175. P. Méndez-Samperio, “The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections,” Peptides, vol. 31, no. 9, pp. 1791–1798, 2010. View at Publisher · View at Google Scholar · View at Scopus
  176. J. Overhage, A. Campisano, M. Bains, E. C. W. Torfs, B. H. A. Rehm, and R. E. W. Hancock, “Human host defense peptide LL-37 prevents bacterial biofilm formation,” Infection and Immunity, vol. 76, no. 9, pp. 4176–4182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  177. S. K. Chennupati, A. G. Chiu, E. Tamashiro et al., “Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis,” American Journal of Rhinology and Allergy, vol. 23, no. 1, pp. 46–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  178. M. Vaara, “New approaches in peptide antibiotics,” Current Opinion in Pharmacology, vol. 9, no. 5, pp. 571–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  179. E. Hell, C. G. Giske, A. Nelson, U. Römling, and G. Marchini, “Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis,” Letters in Applied Microbiology, vol. 50, no. 2, pp. 211–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  180. P. W. Tsai, C. Y. Yang, H. T. Chang, and C. Y. Lan, “Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates,” PLoS ONE, vol. 6, no. 3, Article ID e17755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  181. L. S. Amer, B. M. Bishop, and M. L. van Hoek, “Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella,” Biochemical and Biophysical Research Communications, vol. 396, no. 2, pp. 246–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  182. G. Telford, D. Wheeler, P. Williams et al., “The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3- Oxododecanoyl)-L-homoserine lactone has immunomodulatory activity,” Infection and Immunity, vol. 66, no. 1, pp. 36–42, 1998. View at Scopus
  183. S. R. Chhabra, C. Harty, D. S. W. Hooi et al., “Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-L-homoserine lactone as immune modulators,” Journal of Medicinal Chemistry, vol. 46, no. 1, pp. 97–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  184. A. J. Ritchie, A. O. W. Yam, K. M. Tanabe, S. A. Rice, and M. A. Cooley, “Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule n-(3-oxododecanoyl)-L-homoserine lactone,” Infection and Immunity, vol. 71, no. 8, pp. 4421–4431, 2003. View at Publisher · View at Google Scholar · View at Scopus
  185. K. Tateda, Y. Ishii, M. Horikawa et al., “The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils,” Infection and Immunity, vol. 71, no. 10, pp. 5785–5793, 2003. View at Publisher · View at Google Scholar · View at Scopus
  186. D. T. Hughes and V. Sperandio, “Inter-kingdom signalling: communication between bacteria and their hosts,” Nature Reviews Microbiology, vol. 6, no. 2, pp. 111–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  187. M. Cooley, S. R. Chhabra, and P. Williams, “N-Acylhomoserine lactone-mediated quorum sensing: a twist in the tail and a blow for host immunity,” Chemistry and Biology, vol. 15, no. 11, pp. 1141–1147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  188. C. Wagner, S. Zimmermann, G. Brenner-Weiss et al., “The quorum-sensing molecule N-3-oxododecanoyl homoserine lactone (3OC12-HSL) enhances the host defence by activating human polymorphonuclear neutrophils (PMN),” Analytical and Bioanalytical Chemistry, vol. 387, no. 2, pp. 481–487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  189. T. Karlsson, M. V. Turkina, O. Yakmenko, K. E. Magnusson, and E. Vikström, “The Pseudomonas aeruginosa N-Acylhomoserine Lactone Quorum Senisng Molecules Target IQGAG1 and modulate Epithelial Cell migration,” PLOS Pathogen, vol. 8, no. 10, Article ID e1002953, 2012. View at Publisher · View at Google Scholar
  190. A. Jahoor, R. Patel, A. Bryan et al., “Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer,” Journal of Bacteriology, vol. 190, no. 13, pp. 4408–4415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  191. A. J. Ritchie, C. Whittall, J. J. Lazenby, S. R. Chhabra, D. I. Pritchard, and M. A. Cooley, “The immunomodulatory Pseudomonas aeruginosa signalling molecule N-(3-oxododecanoyl)-L-homoserine lactone enters mammalian cells in an unregulated fashion,” Immunology and Cell Biology, vol. 85, no. 8, pp. 596–602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  192. V. V. Kravchenko, G. F. Kaufmann, J. C. Mathison et al., “N-(3-oxo-acyl)homoserine lactones signal cell activation through a mechanism distinct from the canonical pathogen-associated molecular pattern recognition receptor pathways,” Journal of Biological Chemistry, vol. 281, no. 39, pp. 28822–28830, 2006. View at Publisher · View at Google Scholar · View at Scopus
  193. G. M. Hansch, “Molecular eavesdropping: phagocytic cells spy on bacterial communication,” Journal of Leukocyte Biology, vol. 91, pp. 3–5, 2012.
  194. T. J. Foster, “Immune evasion by staphylococci,” Nature Reviews Microbiology, vol. 3, no. 12, pp. 948–958, 2005. View at Publisher · View at Google Scholar · View at Scopus
  195. I. Fedtke, F. Götz, and A. Peschel, “Bacterial evasion of innate host defenses—the Staphylococcus aureus lesson,” International Journal of Medical Microbiology, vol. 294, no. 2-3, pp. 189–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  196. M. Otto, “Staphylococcal biofilms,” Current Topics in Microbiology and Immunology, vol. 322, pp. 207–228, 2008.
  197. P. Francois, P. H. Tu Quoc, C. Bisognano et al., “Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis,” FEMS Immunology and Medical Microbiology, vol. 35, no. 2, pp. 135–140, 2003. View at Publisher · View at Google Scholar · View at Scopus
  198. M. A. Deighton, R. Borland, and J. A. Capstick, “Virulence of Staphylococcus epidermidis in a mouse model: significance of extracellular slime,” Epidemiology and Infection, vol. 117, no. 2, pp. 267–280, 1996. View at Scopus
  199. B. Gallimore, R. F. Gagnon, R. Subang, and G. K. Richards, “Natural history of chronic Staphylococcus epidermidis foreign body infection in a mouse model,” Journal of Infectious Diseases, vol. 164, no. 6, pp. 1220–1223, 1991. View at Scopus
  200. C. R. Arciola, F. I. Alvi, Y. H. An, D. Campoccia, and L. Montanaro, “Implant infection and infection resistant materials: a mini review,” International Journal of Artificial Organs, vol. 28, no. 11, pp. 1119–1125, 2005. View at Scopus
  201. L. Montanaro, P. Speziale, D. Campoccia, et al., “Scenery of Staphylococcus implant infections in orthopedics,” Future Microbiology, vol. 6, pp. 1329–1349, 2011.
  202. D. De Wit, R. Mulla, M. R. Cowie, J. C. Mason, and K. A. Davies, “Vertebral osteomyelitis due to Staphylococcus epidermidis,” British Journal of Rheumatology, vol. 32, no. 4, pp. 339–341, 1993. View at Scopus
  203. J. O. Galdbart, A. Morvan, N. Desplaces, and N. El Solh, “Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses,” Journal of Clinical Microbiology, vol. 37, no. 5, pp. 1306–1312, 1999. View at Scopus
  204. P. J. Carek, L. M. Dickerson, and J. L. Sack, “Diagnosis and management of osteomyelitis,” American Family Physician, vol. 63, no. 12, pp. 2413–2420, 2001. View at Scopus
  205. F. Günther, G. H. Wabnitz, J. W. Costerton, P. Stroh, et al., “Host defence against Staphylococcus aureus biofilm infection: Phagocytosis of biofilms by polymorphonuclear neutrophils (PMN),” Molecular Immunology, vol. 46, no. 8-9, pp. 1805–1818, 2009. View at Publisher · View at Google Scholar · View at Scopus
  206. J. G. Leid, M. E. Shirtliff, J. W. Costerton, and P. Stoodley, “Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms,” Infection and Immunity, vol. 70, no. 11, pp. 6339–6345, 2002.
  207. F. Guenther, P. Stroh, C. Wagner, U. Obst, and G. M. Hänch, “Phagocytosis of staphylococci biofilms by polymorphonuclear neutrophils: S. aureus and S. epidermidis differ with regard to their susceptibility towards the host defense,” International Journal of Artificial Organs, vol. 32, no. 9, pp. 565–573, 2009. View at Scopus
  208. E. Meyle and G. M. Hänsch, “Bacterial biofilms:the ultimate cause of implant-associated infection,” Giornale Italiano di Ortopedia e Traumatologia, vol. 36, no. 1, pp. s1–s3, 2010.
  209. P. Stroh, F. Günther, E. Meyle, B. Prior, C. Wagner, and G. M. Hänsch, “Host defence against Staphylococcus aureus biofilms by polymorphonuclear neutrophils: oxygen radical production but not phagocytosis depends on opsonisation with immunoglobulin G,” Immunobiology, vol. 216, no. 3, pp. 351–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  210. S. A. Kristian, T. A. Birkenstock, U. Sauder, D. Mack, F. Götz, and R. Landmann, “Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing,” Journal of Infectious Diseases, vol. 197, no. 7, pp. 1028–1035, 2008. View at Publisher · View at Google Scholar · View at Scopus
  211. L. R. Thurlow, M. L. Hanke, T. Fritz et al., “Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo,” Journal of Immunology, vol. 186, no. 11, pp. 6585–6596, 2011. View at Publisher · View at Google Scholar · View at Scopus
  212. E. Meyle, G. Brenner-Weiss, U. Obst, B. Prior, and G. M. Hänsch, “Immune defence against S. epidermidis biofilms: components of the extracellular polymeric substance activate distinct bactericidal mechanisms of phagocytic cells,” International Journal of Artificial Organs. In press.
  213. M. A. Noble, P. E. Reid, C. M. Park, and V. Y. H. Chan, “Inhibition of human neutrophil bacteriocidal activity by extracellular substance from slime-producing Staphylococcus epidermidis,” Diagnostic Microbiology and Infectious Disease, vol. 4, no. 4, pp. 335–339, 1986. View at Scopus
  214. G. M. Johnson, D. A. Lee, and W. E. Regelmann, “Interference with granulocyte function by Staphylococcus epidermidis slime,” Infection and Immunity, vol. 54, no. 1, pp. 13–20, 1986. View at Scopus
  215. Q. N. Myrvik, W. Wagner, E. Barth, P. Wood, and A. G. Gristina, “Effects of extracellular slime produced by Staphylococcus epidermidis on oxidative responses of rabbit alveolar macrophages,” Journal of Investigative Surgery, vol. 2, no. 4, pp. 381–389, 1989. View at Scopus
  216. J. Rodgers, F. Phillips, and C. Olliff, “The effects of extracellular slime from Staphylococcus epidermidis on phagocytic ingestion and killing,” FEMS Immunology and Medical Microbiology, vol. 9, no. 2, pp. 109–115, 1994. View at Publisher · View at Google Scholar · View at Scopus
  217. C. Vuong, S. Kocianova, J. M. Voyich et al., “A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence,” Journal of Biological Chemistry, vol. 279, no. 52, pp. 54881–54886, 2004. View at Publisher · View at Google Scholar · View at Scopus
  218. M. E. Rupp, J. S. Ulphani, P. D. Fey, and D. Mack, “Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model,” Infection and Immunity, vol. 67, no. 5, pp. 2656–2659, 1999. View at Scopus
  219. R. Rupp and D. Boichard, “Genetic parameters for clinical mastitis, somatic cell score, production, udder type traits, and milking ease in first lactation Holsteins,” Journal of Dairy Science, vol. 82, no. 10, pp. 2198–2204, 1999. View at Scopus
  220. J. O. Galdbart, J. Allignet, H. S. Tung, R. Cécilia, and N. El Solh, “Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prostheses,” Journal of Infectious Diseases, vol. 182, no. 1, pp. 351–355, 2000. View at Publisher · View at Google Scholar · View at Scopus
  221. E. Barth, Q. M. Myrvik, W. Wagner, and A. G. Gristina, “In vitro and in vivo comparative colonization of Staphylociccus aureus and Staphylococcus epidermidis on orthopedic implants,” Biomaterials, vol. 10, pp. 325–328, 1989.
  222. M. Otto, R. Süßmuth, G. Jung, and F. Götz, “Structure of the pheromone peptide of the Staphylococcus epidermis agr system,” FEBS Letters, vol. 424, no. 1-2, pp. 89–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  223. C. Vuong, C. Gerke, G. A. Somerville, E. R. Fischer, and M. Otto, “Quorum-sensing control of biofilm factors in Staphylococcus epidermidis,” Journal of Infectious Diseases, vol. 188, no. 5, pp. 706–718, 2003. View at Publisher · View at Google Scholar · View at Scopus
  224. C. Vuong, M. Dürr, A. B. Carmondy, A. Peschel, S. J. Klebanoff, and M. Otto, “Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins,” Cellular Microbiology, vol. 6, no. 8, pp. 753–759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  225. Y. Yao, C. Vuong, S. Kocianova et al., “Characterization of the Staphylococcus epidermidis accessory-gene regulator response: quorum-sensing regulation of resistance to human innate host defense,” Journal of Infectious Diseases, vol. 193, no. 6, pp. 841–848, 2006. View at Publisher · View at Google Scholar · View at Scopus
  226. I. K. Mullarky, C. Su, N. Frieze, Y. H. Park, and L. M. Sordillo, “Staphylococcus aureus agr genotypes with enterotoxin production capabilities can resist neutrophil bactericidal activity,” Infection and Immunity, vol. 69, no. 1, pp. 45–51, 2001. View at Publisher · View at Google Scholar · View at Scopus
  227. J. A. Smith, “Neutrophils, host defense, and inflammation: a double-edged sword,” Journal of Leukocyte Biology, vol. 56, no. 6, pp. 672–686, 1994. View at Scopus
  228. G. Doring, “The role of neutrophil elastase in chronic inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 6, pp. S114–S117, 1994. View at Scopus
  229. C. Wagner, U. Obst, and G. M. Hänsch, “Implant-associated posttraumatic osteomyelitis: collateral damage by local host defense?” International Journal of Artificial Organs, vol. 28, no. 11, pp. 1172–1180, 2005. View at Scopus
  230. C. R. Arciola, Y. H. An, D. Campoccia, M. E. Donati, and L. Montanaro, “Etiology of implant orthopedic infections: a survey on 1027 clinical isolates,” International Journal of Artificial Organs, vol. 28, no. 11, pp. 1091–1100, 2005. View at Scopus
  231. C. R. Arciola, “Host defense against implant infection: the ambivalent role of phagocytosis,” International Journal of Artificial Organs, vol. 33, no. 9, pp. 565–567, 2010. View at Scopus
  232. J. Savill, “Apoptosis in resolution of inflammation,” Journal of Leukocyte Biology, vol. 61, no. 4, pp. 375–380, 1997. View at Scopus
  233. C. N. Serhan and J. Savill, “Resolution of inflammation: the beginning programs the end,” Nature Immunology, vol. 6, no. 12, pp. 1191–1197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  234. M. Faurschou and N. Borregaard, “Neutrophil granules and secretory vesicles in inflammation,” Microbes and Infection, vol. 5, no. 14, pp. 1317–1327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  235. T. S. Walker, K. L. Tomlin, G. S. Worthen et al., “Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils,” Infection and Immunity, vol. 73, no. 6, pp. 3693–3701, 2005. View at Publisher · View at Google Scholar · View at Scopus
  236. Q. M. Parks, R. L. Young, K. R. Poch, K. C. Malcolm, M. L. Vasil, and J. A. Nick, “Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy,” Journal of Medical Microbiology, vol. 58, no. 4, pp. 492–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  237. U. Obst, S.-M. Marten, C. Niessner, E. Hartwig, M. Korsch, and M. Walther, “Diversity of patients microflora on orthopaedic and dental implants,” International Journal of Artificial Organs. In press.
  238. M. Oga, Y. Sugioka, C. D. Hobgood, A. G. Gristina, and Q. N. Myrvik, “Surgical biomaterials and differential colonization by Staphylococcus epidermidis,” Biomaterials, vol. 9, no. 3, pp. 285–289, 1988. View at Scopus
  239. J. Cordero, L. Munuera, and M. D. Folgueira, “Influence of metal implants on infection: an experimental study in rabbits,” Journal of Bone and Joint Surgery Series B, vol. 76, no. 5, pp. 717–720, 1994. View at Scopus
  240. J. C. Pinilla, D. F. Ross, T. Martin, and H. Crump, “Study of the incidence of intravascular catheter infection and associated septicemia in critically ill patients,” Critical Care Medicine, vol. 11, no. 1, pp. 21–25, 1983. View at Scopus
  241. I. Raad, “Intravascular-catheter-related infections,” Lancet, vol. 351, no. 9106, pp. 893–898, 1998. View at Publisher · View at Google Scholar · View at Scopus
  242. J. A. Crump and P. J. Collignon, “Intravascular catheter-associated infections,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 19, no. 1, pp. 1–8, 2000. View at Scopus
  243. B. W. Trautner and R. O. Darouiche, “Role of biofilm in catheter-associated urinary tract infection,” American Journal of Infection Control, vol. 32, no. 3, pp. 177–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  244. N. Safdar, D. M. Kluger, and D. G. Maki, “A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies,” Medicine, vol. 81, no. 6, pp. 466–479, 2002. View at Publisher · View at Google Scholar · View at Scopus
  245. W. Zimmerli and P. E. Ochsner, “Management of infection associated with prosthetic joints,” Infection, vol. 31, no. 2, pp. 99–108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  246. J. L. Del Pozo and R. Patel, “Infection associated with prosthetic joints,” New England Journal of Medicine, vol. 361, no. 8, pp. 787–794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  247. F. S. Rosen, M. D. Cooper, and R. J. P. Wedgwood, “Medical progress: the primary immunodeficiencies,” New England Journal of Medicine, vol. 333, no. 7, pp. 431–440, 1995. View at Publisher · View at Google Scholar · View at Scopus
  248. R. S. Geha, L. D. Notarangelo, J. L. Casanova et al., “Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee,” The Journal of Allergy and Clinical Immunology, vol. 120, no. 4, pp. 776–794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  249. J. L. Casanova, C. Fieschi, J. Bustamante et al., “From idiopathic infectious diseases to novel primary immunodeficiencies,” Journal of Allergy and Clinical Immunology, vol. 116, no. 2, pp. 426–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  250. J. L. Casanova and L. Abel, “Primary immunodeficiencies: a field in its infancy,” Science, vol. 317, no. 5838, pp. 617–619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  251. J. L. Casanova and L. Abel, “Human genetics of infectious diseases: a unified theory,” EMBO Journal, vol. 26, no. 4, pp. 915–922, 2007. View at Publisher · View at Google Scholar · View at Scopus